SMS Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 196.64 | 249.62 | 175.48 |
| Operating Expense | 157.19 | 206.85 | 140.05 |
| Net Profit | 18.21 | 20.62 | 17.17 |
| Net Profit Margin | 9.26 | 8.26 | 9.78 |
| Earning Per Share | 2.05 | 2.43 | 2.03 |
| EBIDTA | 38.80 | 38.98 | 35.06 |
| Effective Tax Rate | 12.67 | 10.87 | 14.08 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 196.64 |
| Operating Expense | 157.19 |
| Net Profit | 18.21 |
| Net Profit Margin | 9.26 |
| Earning Per Share | 2.05 |
| EBIDTA | 38.80 |
| Effective Tax Rate | 12.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 782.75 | 709.26 | 522.05 |
| Operating Expenses Annual | 642.77 | 592.42 | 467.38 |
| Operating Profit Annual | 146.20 | 121.30 | 59.59 |
| Interest Annual | 18.54 | 23.46 | 21.91 |
| Depreciation | 32.86 | 30.01 | 30.79 |
| Net Profit Annual | 68.38 | 49.42 | 4.08 |
| Tax Annual | 24.94 | 16.91 | 1.47 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 782.75 |
| Operating Expenses Annual | 642.77 |
| Operating Profit Annual | 146.20 |
| Interest Annual | 18.54 |
| Depreciation | 32.86 |
| Net Profit Annual | 68.38 |
| Tax Annual | 24.94 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 36.04 | 7.31 | 46.58 |
| Cash Flow from Operations | 81.71 | 50.12 | 22.45 |
| Cash Flow from Investing | -123.44 | -52.07 | -29.76 |
| Cash Flow from Financing | 47.08 | 30.68 | -31.97 |
| Cash Flow at the End | 41.39 | 36.04 | 7.31 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 36.04 |
| Cash Flow from Operations | 81.71 |
| Cash Flow from Investing | -123.44 |
| Cash Flow from Financing | 47.08 |
| Cash Flow at the End | 41.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.50 | 16.14 | 10.76 |
| PBIT Margin (%) | 13.39 | 11.95 | 4.96 |
| PBT Margin (%) | 12.67 | 11.44 | 4.73 |
| Net PROFIT Margin (%) | 8.18 | 6.57 | 0.74 |
| Return On Networth / Equity (%) | 11 | 9.28 | 0.83 |
| Return On Networth /Employed (%) | 12.18 | 11.22 | 3.65 |
| Return On Assets (%) | 7.45 | 6.17 | 0.54 |
| Total Debt / Equity (X) | 0.48 | 0.50 | 0.52 |
| Asset Turnover Ratio (%) | 0.91 | 0.94 | 0.73 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.50 |
| PBIT Margin (%) | 13.39 |
| PBT Margin (%) | 12.67 |
| Net PROFIT Margin (%) | 8.18 |
| Return On Networth / Equity (%) | 11 |
| Return On Networth /Employed (%) | 12.18 |
| Return On Assets (%) | 7.45 |
| Total Debt / Equity (X) | 0.48 |
| Asset Turnover Ratio (%) | 0.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 532.98 | 437.26 | 412.02 |
| Total Current Assets Annual | 554.46 | 533.89 | 410.65 |
| Non Current Assets Annual | 631.64 | 534.36 | 503.54 |
| Total Shareholders Funds Annual | 673.07 | 570.49 | 495.10 |
| Total Assets Annual | 1,186.10 | 1,068.25 | 914.18 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 532.98 |
| Total Current Assets Annual | 554.46 |
| Non Current Assets Annual | 631.64 |
| Total Shareholders Funds Annual | 673.07 |
| Total Assets Annual | 1,186.10 |
EPS (INR)
Expected
2.31
Reported
2.31
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 4.80%
Sep 2024
EPS beaten by 0.00%
